• 1. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 4. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Disaccharides
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Disaccharides

Introduction to Heparin Disaccharide I-S, Tetrasodium Salt (CAS No. 136098-10-7)

Heparin Disaccharide I-S, Tetrasodium Salt, a compound with the chemical identifier CAS No. 136098-10-7, is a significant derivative in the field of pharmaceutical chemistry and biochemistry. This tetrasodium salt form of a heparin disaccharide has garnered considerable attention due to its unique structural properties and biological activities. Heparin, a naturally occurring polysaccharide, is widely recognized for its anticoagulant properties, and specific disaccharide fragments, such as the one represented by Heparin Disaccharide I-S, Tetrasodium Salt, offer insights into the mechanisms of heparin's action and potential therapeutic applications.

The structure of Heparin Disaccharide I-S, Tetrasodium Salt consists of two sugar units linked by an α-(1→4) glycosidic bond, with specific sulfation patterns that contribute to its biological activity. The tetrasodium salt form enhances solubility and stability, making it a valuable compound for various research and industrial applications. Recent studies have highlighted the importance of heparin disaccharides in modulating biological processes, including anticoagulation, inflammation, and cell growth. The precise sulfation pattern of Heparin Disaccharide I-S, Tetrasodium Salt is critical in determining its interaction with target proteins and enzymes.

In the realm of drug development, Heparin Disaccharide I-S, Tetrasodium Salt has been explored as a potential lead compound for novel therapeutics. Its ability to bind to various growth factors and cytokines makes it a candidate for applications in regenerative medicine and anti-inflammatory treatments. For instance, research has demonstrated that this disaccharide can inhibit the activity of certain proteases involved in blood clotting and inflammation, suggesting its utility in developing new anticoagulant and anti-inflammatory drugs.

Moreover, the tetrasodium salt form of heparin disaccharide has been investigated for its role in enhancing drug delivery systems. The high affinity of this compound for proteins allows it to be used as a carrier or adjuvant in formulations designed to improve bioavailability and targeted delivery of therapeutic agents. This property is particularly relevant in the development of nucleic acid-based therapies, where heparin derivatives can facilitate the cellular uptake of nucleic acids such as siRNA and mRNA.

Recent advancements in mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy have enabled more detailed structural elucidation of compounds like Heparin Disaccharide I-S, Tetrasodium Salt. These techniques have provided insights into the conformational dynamics and binding interactions of heparin disaccharides with biological targets. Such structural information is crucial for rational drug design and optimization. Additionally, computational modeling studies have been employed to predict the binding affinities and mechanisms of action of these compounds, further aiding in their development as therapeutic agents.

The pharmaceutical industry has also shown interest in Heparin Disaccharide I-S, Tetrasodium Salt for its potential role in diagnostic applications. Its specific interactions with biomarkers can be leveraged to develop sensitive and selective diagnostic assays for various diseases. For example, research has indicated that this disaccharide can bind to specific proteins associated with cancer cell proliferation, making it a promising candidate for early detection and monitoring of tumor progression.

In conclusion, Heparin Disaccharide I-S, Tetrasodium Salt (CAS No. 136098-10-7) represents a significant advancement in the field of biomedical research and drug development. Its unique structural features and biological activities make it a valuable compound for exploring new therapeutic strategies across multiple domains. As research continues to uncover new applications and mechanisms of action for this compound, its importance in modern medicine is likely to grow further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)